MedTrace Logo

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

NCT03291652 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-02-24

No results posted yet for this study

Summary

The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).

Conditions

Interventions

DIAGNOSTIC_TEST

DSA/3DRA

DSA/3DRA

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Thomas Wai Hong LEUNG, FRCP · Chinese University of Hong Kong

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2026-12-23
Completion
2027-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291652 on ClinicalTrials.gov